What Researchers Did
Researchers investigated the effects of hyperbaric oxygen therapy (HBOT) on 31 patients experiencing post-COVID-19 syndrome symptoms, administering 15 HBOT sessions and assessing various physiological and psychological parameters before and after treatment.
What They Found
The 31 patients showed significant improvements in quality of life, endurance, strength, working memory, and attention after 15 HBOT sessions. Specific improvements included some spirometric parameters, anion gap, and lactate levels, with beneficial effects maintained over time. However, no changes were observed in pH, pO2, pCO2, glucose, or excess alkaline values.
What This Means for Canadian Patients
Canadian patients experiencing persistent post-COVID-19 symptoms might find hyperbaric oxygen therapy (HBOT) to be a potential treatment to alleviate their symptoms. This therapy could offer a practical, non-pharmacological approach to improve quality of life, physical endurance, and cognitive functions like memory and attention.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A significant limitation of this study is its small sample size of 31 patients, which restricts the generalizability of the findings.